Lardaro, A.; Quarta, L.; Pagnotta, S.; Sodero, G.; Mariani, S.; Del Ben, M.; Desideri, G.; Ettorre, E.; Baratta, F.
Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline. Biomedicines 2024, 12, 1750.
https://doi.org/10.3390/biomedicines12081750
AMA Style
Lardaro A, Quarta L, Pagnotta S, Sodero G, Mariani S, Del Ben M, Desideri G, Ettorre E, Baratta F.
Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline. Biomedicines. 2024; 12(8):1750.
https://doi.org/10.3390/biomedicines12081750
Chicago/Turabian Style
Lardaro, Antonio, Ludovica Quarta, Stefania Pagnotta, Giorgio Sodero, Sandro Mariani, Maria Del Ben, Giovambattista Desideri, Evaristo Ettorre, and Francesco Baratta.
2024. "Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline" Biomedicines 12, no. 8: 1750.
https://doi.org/10.3390/biomedicines12081750
APA Style
Lardaro, A., Quarta, L., Pagnotta, S., Sodero, G., Mariani, S., Del Ben, M., Desideri, G., Ettorre, E., & Baratta, F.
(2024). Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline. Biomedicines, 12(8), 1750.
https://doi.org/10.3390/biomedicines12081750
